2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a persistent organic pollutant that is strongly associated with a number of human diseases and birth defects, including cleft palate. Transforming growth factor (TGF) plays a significant role during mammalian palatogenesis. However, the epigenetic mechanism of transforming growth factors in the process of TCDD-induced cleft palate is unclear. The purpose of this research was to investigate the relationship and potential mechanism between TGF-β2/3 promoter DNA methylation and Smad signaling during TCDD-induced cleft palate. Pregnant C57BL/6N mice were exposed to 64 µg/kg TCDD on gestational day 10 (GD10) to establish the cleft palate model and palatal tissues of embryos were collected on GD13, GD14, and GD15 for subsequent experiments. TGF-β2/3 mRNA expression, TGF-β2/3 promoter methylation, and Smad signaling molecules expression were assessed in the palate of the two groups. The results showed that the incidence of cleft palate was 94.7% in the TCDD-treated group whereas no cleft palate was found in the control group. TCDD-treated group altered specific CpG sites of TGF-β2/3 promoter methylation. Compared to the control group, the proliferation of mouse embryonic palate mesenchymal stromal cells (MEPM), the expressions of TGF-β2/3, p-Smad2, and Smad4 were all reduced, while the expression of Smad7 was significantly increased in the atAR group. Smad signaling was downregulated by TCDD. Therefore, we suggest that TGF-β2/3 promoter methylation and Smad signaling may be involved in TCDD-induced cleft palate formation in fetal mice.
ParkerSMaiCCanfieldMRickardRWangYMeyerRAndersonPMasonCCollinsJKirbyRCorreaA.Updated national birth prevalence estimates for selected birth defects in the United States, 2004–2006. Birth Defects Res A Clin Mol Teratol2010;
88:1008–16
2.
BeatyTRuczinskiIMurrayJMarazitaMMungerRHetmanskiJMurrayTRedettRFallinMLiangKWuTPatelPJinSZhangTSchwenderHWu-ChouYChenPChongSCheahFYeowVYeXWangHHuangSJabsEShiBWilcoxALieRJeeSChristensenKDohenyKPughELingHScottA.Evidence for gene-environment interaction in a genome wide study of nonsyndromic cleft palate. Genet Epidemiol2011;
35:469–78
3.
BushJJiangR.Palatogenesis: morphogenetic and molecular mechanisms of secondary palate development. Development2012;
139:231–43
4.
HoytACanfieldMRomittiPBottoLAnderkaMKrikovSTarpeyMFeldkampM.Associations between maternal periconceptional exposure to secondhand tobacco smoke and major birth defects. Am J Obstet Gynecol2016;
215:613.e1–13.e11
5.
JiaZShiBChenCShiJWuJXuX.Maternal malnutrition, environmental exposure during pregnancy and the risk of non-syndromic orofacial clefts. Oral Diseases2011;
17:584–9
6.
VorderstrasseBFentonSBohnACundiffJLawrenceB.A novel effect of dioxin: exposure during pregnancy severely impairs mammary gland differentiation. Toxicol Sci2004;
78:248–57
7.
LiuXLiXTaoYLiNJiMZhangXChenYHeZYuKYuZ.TCDD inhibited the osteogenic differentiation of human fetal palatal mesenchymal cells through AhR and BMP-2/TGF-β/smad signaling. Toxicology2020;
431:152353
8.
YoshiokaWTohyamaC.Mechanisms of developmental toxicity of dioxins and related compounds. Int J Mol Sci2019;
20:617
9.
SongYvan den BergPMarkoulakiSSoldnerFDall'AgneseAHenningerJDrotarJRosenauNCohenMYoungRSemrauSStelzerYJaenischR.Dynamic enhancer DNA methylation as basis for transcriptional and cellular heterogeneity of ESCs. Mol Cell2019;
75:905–20.e6
10.
ZhangWZhouSGaoYSongHJiaoXWangXLiY.Alterations in DNA methyltransferases and methyl-CpG binding domain proteins during cleft palate formation as induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice. Mol Med Rep2018;
17:5396–401
11.
LongHKingHPatientROdomDKloseR.Protection of CpG islands from DNA methylation is DNA-encoded and evolutionarily conserved. Nucleic Acids Res2016;
44:6693–706
12.
KafriTArielMBrandeisMShemerRUrvenLMcCarreyJCedarHRazinA.Developmental pattern of gene-specific DNA methylation in the mouse embryo and germ line. Genes Dev1992;
6:705–14
13.
KakutaniTJeddelohJFlowersSMunakataKRichardsE.Developmental abnormalities and epimutations associated with DNA hypomethylation mutations. Proc Natl Acad Sci U S A1996;
93:12406–11
14.
KuriyamaMUdagawaAYoshimotoSIchinoseMSatoKYamazakiKMatsunoYShiotaKMoriC.DNA methylation changes during cleft palate formation induced by retinoic acid in mice. Cleft Palate Craniofac J2008;
45:545–51
15.
FitzpatrickDDenhezFKondaiahPAkhurstR.Differential expression of TGF beta isoforms in murine palatogenesis. Development1990;
109:585–95
16.
IwataJParadaCChaiY.The mechanism of TGF-β signaling during palate development. Oral Dis2011;
17:733–44
17.
SanfordLOrmsbyIGittenberger-de GrootASariolaHFriedmanRBoivinGCardellEDoetschmanT.TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development1997;
124:2659–70
18.
KaartinenVCuiXHeisterkampNGroffenJShulerC.Transforming growth factor-beta3 regulates transdifferentiation of medial edge epithelium during palatal fusion and associated degradation of the basement membrane. Dev Dyn1997;
209:255–60
19.
GaidoKManessSLeonardLGreenleeW2.3,7,8-Tetrachlorodibenzo-p-dioxin-dependent regulation of transforming growth factors-alpha and -beta 2 expression in a human keratinocyte cell line involves both transcriptional and post-transcriptional control. J Biol Chem1992;
267:24591–5
20.
del RíoABarrioMMurilloJMaldonadoELópez-GordilloYMartínez-SanzEMartínezMMartínez-ÁlvarezC.Analysis of the presence of cell proliferation-related molecules in the tgf-β3 null mutant mouse palate reveals misexpression of EGF and msx-1. Cells Tissues Organs2011;
193:135–50
21.
FitchettJHayE.Medial edge epithelium transforms to mesenchyme after embryonic palatal shelves fuse. Dev Biol1989;
131:455–74
22.
LeeDBarlowKGaidoK.The actions of 2,3,7,8-tetrachlorodibenzo-p-dioxin on transforming growth factor-beta2 promoter activity are localized to the TATA box binding region and controlled through a tyrosine kinase-dependent pathway. Toxicol Appl Pharmacol1996;
137:90–9
23.
GanLFuYLiuXQiuLWuSTianXLiuYWeiG.Transforming growth factor-beta3 expression up-regulates on cleft palates induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice. Toxicol Ind Health2009;
25:473–8
24.
YuanXLiuLPuYZhangXHeXFuY2.3,7,8-Tetrachlorodibenzo-p-dioxin induces a proteomic pattern that defines cleft palate formation in mice. Food Chem Toxicol2012;
50:2270–4
25.
AlMegbelAShulerC.SMAD2 overexpression rescues the TGF-β3 null mutant mice cleft palate by increased apoptosis. Differentiation2020;
111:60–9
26.
CuiXWarburtonDZhaoJCroweDShulerC.Immunohistochemical localization of TGF-beta type II receptor and TGF-beta3 during palatogenesis in vivo and in vitro. Int J Dev Biol1998;
42:817–20
27.
LiuXQiJTaoYZhangHYinJJiMGaoZLiZLiNYuZ.Correlation of proliferation, TGF-β3 promoter methylation, and smad signaling in MEPM cells during the development of ATRA-induced cleft palate. Reproduct Toxicol2016;
61:1–9
28.
Haarmann-StemmannTBotheHAbelJ.Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways. Biochem Pharmacol2009;
77:508–20
29.
KomuraJOkadaTOnoT.Repression of transient expression by DNA methylation in transcribed regions of reporter genes introduced into cultured human cells. Biochim Biophys Acta1995;
1260:73–8
30.
PanXChenZHuangRYaoYMaG.Transforming growth factor β1 induces the expression of collagen type I by DNA methylation in cardiac fibroblasts. PLoS One2013;
8:e60335
31.
AbbottBProbstMPerdewGBuckalewA.AH receptor, ARNT, glucocorticoid receptor, EGF receptor, EGF, TGF alpha, TGF beta 1, TGF beta 2, and TGF beta 3 expression in human embryonic palate, and effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Teratology1998;
58:30–43
32.
NikAJohanssonJGhiamiMReyahiACarlssonP.Foxf2 is required for secondary palate development and tgfβ signaling in palatal shelf mesenchyme. Dev Biol2016;
415:14–23
33.
LiCLanYJiangR.Molecular and cellular mechanisms of palate development. J Dent Res2017;
96:1184–91
34.
NakajimaATanakaEItoYMaenoMIwataKShimizuNShulerC.The expression of TGF-β3 for epithelial-mesenchyme transdifferentiated MEE in palatogenesis. J Mol Hist2010;
41:343–55
35.
DerynckRZhangY.Smad-dependent and smad-independent pathways in TGF-beta family signalling. Nature2003;
425:577–84
36.
LiuLLiuXRenXTianYChenZXuXDuYJiangCFangYLiuZFanBZhangQJinGYangXZhangX.Smad2 and Smad3 have differential sensitivity in relaying TGFβ signaling and inversely regulate early lineage specification. Sci Rep2016;
6:21602
37.
MiyazawaKMiyazonoK.Regulation of TGF-β family signaling by inhibitory smads. Cold Spring Harb Perspect Biol2017;
9:a022095
38.
YumotoKThomasPLaneJMatsuzakiKInagakiMNinomiya-TsujiJScottGRayMIshiiMMaxsonRMishinaYKaartinenV.TGF-β-activated kinase 1 (Tak1) mediates agonist-induced smad activation and linker region phosphorylation in embryonic craniofacial neural crest-derived cells. J Biol Chem2013;
288:13467–80
39.
LiXZhangLYinXGaoZZhangHLiuXPanXLiNYuZ.Retinoic acid remodels extracellular matrix (ECM) of cultured human fetal palate mesenchymal cells (hFPMCs) through down-regulation of TGF-β/smad signaling. Toxicol Lett2014;
225:208–15
40.
CuiXShiomiNChenJSaitoTYamamotoTItoYBringasPChaiYShulerC.Overexpression of Smad2 in tgf-beta3-null mutant mice rescues cleft palate. Dev Biol2005;
278:193–202
